Longly Capital
Longly Capital is a venture capital firm established in 2014 and based in Shanghai, China. The firm specializes in early-stage investments, targeting sectors such as healthcare, entertainment, artificial intelligence, and the industrial Internet. With a focus on the rapidly growing Chinese market, Longly Capital aims to capitalize on the country's era of mass innovation, believing that it will continue to yield significant advancements and entrepreneurial opportunities. The firm has also launched the Lianli Venture Capital Fund to support the development of high-tech and innovative companies in China.
Paytner is a Tokyo-based company that develops and operates a platform designed to support freelancers and small to medium-sized enterprises (SMEs) in securing financing. Founded in 2019, the company addresses the challenges faced by the growing freelance population in Japan, including issues related to funding and workplace harassment. Paytner's platform enables clients to receive rewards on the same day they register invoice information sent to their business partners, streamlining the payment process. By focusing on improving the working environment for freelancers and SMEs, Paytner aims to alleviate various obstacles that hinder their financial and professional growth.
Bigfish Bio-tech Co., Ltd. is based in Hangzhou Future Science City and specializes in the research and development of molecular detection instruments and reagents. With over 15 years of expertise, the company focuses on creating diagnostic solutions that observe changes in genetic material within patients. Bigfish Bio-tech's product offerings include nucleic acid purification instruments, PCR-related tools, and various diagnostic reagents. The company employs advanced technologies such as Internet of Things modules and a big data management platform, along with an automatic pipetting robotic arm, to deliver intelligent and comprehensive solutions for the healthcare industry. Its commitment to high-quality, cost-effective products is supported by a strong team dedicated to innovation in molecular medicine diagnostics.
Coyote Bioscience Co., Ltd. specializes in the development of battery-powered molecular diagnostic devices and genetic molecular diagnostic technology. Founded in 2009 and headquartered in Beijing, China, with additional offices in Columbia, Maryland, and a subsidiary in Jiangsu, the company focuses on the research and development of clinical diagnostic devices, reagents, and detection systems. Its product offerings include quantitative polymerase chain reaction (qPCR) systems, a real-time PCR system, and a MD-box-lab for nucleic acid detection. Additionally, Coyote manufactures tools for sample handling, such as dry baths for temperature control and tissue grinders for sample preparation. The company’s technologies are utilized for rapid screening of infectious diseases, individualized medication guidance, and monitoring of intestinal microbiota in infants and young children.
Independent medical test laboratory, serving women and children based in Beijing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.